Avapritinib Rollover Study

Clinical trial NCT06748001 · RECRUITING

Trial details

NCT number: NCT06748001
Sponsor: Blueprint Medicines Corporation
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Mastocytosis, Systemic

Start date: 2024-11-28
Primary completion: 2027-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.